2015Chinese Journal of NeuromedicineRequires access

Early administration of cyclosporin A providing neuroprotection in experimental rats with cerebral hemorrhage

Haiwang Zhang, Ling Zhang, Bin Wang, Hao Li, Changren Huang, Yang Ming, Jinghu Dong, Fubing Yang, Yong Jiang, Liang Liu, Xiangguo Xia, Hua Feng, Ligang Chen

Open publisher page 0 citations

Abstract

Objective To assess the impact of early administration of cyclosporine A (CsA) in neuroprotection in experimental rats with intracerebral hemorrhage (ICH). Methods Ninety-six male SD rats were randomly divided into sham-operated group, ICH+vehicle group, ICH+CsA 5 mg group and ICH+ CsA 10 mg group (n=24). And 100 mL autologous blood from the right femoral artery was injected into the right basal ganglia to induce ICH models in the later three groups. Tail vein administration of 5 mg/kg and 10 mg/kg CsA was performed in the later two groups 15 min after ICH, and then, once every 24 h. Twenty-four h after ICH, MR imaging was performed; brain water content was measured by Wet and dry weight method; blood-brain barrier permeability was detected by Evans blue (EB) method. Seventy-two h after ICH, NISSL and TUNEL were employed to detect the cell apoptosis, and neurological deficit scale scores were recorded. Results Twenty-four h after ICH, ICH+ vehicle group had significantly severer cerebral edema, significantly increased water content of brain tissues (79.55%±0.09%) and EB content ([5.53±0.26] μg/g) as compared with sham-operated group (78.22%±0.14%, [2.55±0.13] μg/g), with significant differences (P<0.05); ICH+ CsA 10 mg group had significantly alleviated cerebral edema, significantly decreased water content of brain tissues (78.70%±0.07%) and EB content ([3.24±0.16] μg/g) as compared with ICH+vehicle group and ICH+ CsA 5 mg group (78.91%±0.11%, [4.12±0.12] μg/g), with significant differences (P<0.05). Seventy-two h after ICH, ICH+ vehicle group had decreased number of brain tissue cells around the hematoma, increased apoptosis cells (180.00±12.43) and decreased neurological deficit scale scores as compared with sham-operated group (26.00±7.29), with significant differences (P<0.05); ICH+CsA 10 mg group had decreased apoptosis cells (69.33±11.31) and increased neurological deficit scale scores as compared with ICH+vehicle group and ICH+CsA 5 mg group (95.00±8.99), with significant differences (P<0.05). Conclusion Early application of CsA can improve brain edema, blood-brain barrier permeability, decrease neuronal apoptosis and improve neurological deficit scale scores after ICH. Key words: Intracerebral hemorrhage; Cyclosporin A; Brain edema; Blood brain barrier; Neuronal apoptosis

About this research paper

What this paper is about

Objective To assess the impact of early administration of cyclosporine A (CsA) in neuroprotection in experimental rats with intracerebral hemorrhage (ICH). Methods Ninety-six male SD rats were randomly divided into sham-operated group, ICH+vehicle group, ICH+CsA 5 mg group and ICH+ CsA 10 mg group (n=24). And 100 mL autologous blood from the right femoral artery was injected into the right basal ganglia to induce ICH models in the later three groups. Tail vein administration of 5 mg/kg and 10 mg/kg CsA was performed in the later two groups 15 min after ICH, and then, once every 24 h. Twenty-four h after ICH, MR imaging was performed; brain water content was measured by Wet and dry weight method; blood-brain barrier permeability was detected by Evans blue (EB) method. Seventy-two h after ICH, NISSL and TUNEL were employed to detect the cell apoptosis, and neurological deficit scale scores were recorded. Results Twenty-four h after ICH, ICH+ vehicle group had significantly severer cerebral edema, significantly increased water content of brain tissues (79.55%±0.09%) and EB content ([5.53±0.26] μg/g) as compared with sham-operated group (78.22%±0.14%, [2.55±0.13] μg/g), with significant differences (P<0.05); ICH+ CsA 10 mg group had significantly alleviated cerebral edema, significantly decreased water content of brain tissues (78.70%±0.07%) and EB content ([3.24±0.16] μg/g) as compared with ICH+vehicle group and ICH+ CsA 5 mg group (78.91%±0.11%, [4.12±0.12] μg/g), with significant differences (P<0.05). Seventy-two h after ICH, ICH+ vehicle group had decreased number of brain tissue cells around the hematoma, increased apoptosis cells (180.00±12.43) and decreased neurological deficit scale scores as compared with sham-operated group (26.00±7.29), with significant differences (P<0.05); ICH+CsA 10 mg group had decreased apoptosis cells (69.33±11.31) and increased neurological deficit scale scores as compared with ICH+vehicle group and ICH+CsA 5 mg group (95.00±8.99), with significant differences (P<0.05). Conclusion Early application of CsA can improve brain edema, blood-brain barrier permeability, decrease neuronal apoptosis and improve neurological deficit scale scores after ICH. Key words: Intracerebral hemorrhage; Cyclosporin A; Brain edema; Blood brain barrier; Neuronal apoptosis

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To assess the impact of early administration of cyclosporine A (CsA) in neuroprotection in experimental rats with intracerebral hemorrhage (ICH). Methods Ninety-six male SD rats were randomly divided into sham-operated group, ICH+vehicle group, ICH+CsA 5 mg group and ICH+ CsA 10 mg group (n=24). And 100 mL autologous blood from the right femoral artery was injected into the right basal ganglia to induce ICH models in the later three groups. Tail vein administration of 5 mg/kg and 10 mg/kg CsA was performed in the later two groups 15 min after ICH, and then, once every 24 h. Twenty-four h after ICH, MR imaging was performed; brain water content was measured by Wet and dry weight method; blood-brain barrier permeability was detected by Evans blue (EB) method. Seventy-two h after ICH, NISSL and TUNEL were employed to detect the cell apoptosis, and neurological deficit scale scores were recorded. Results Twenty-four h after ICH, ICH+ vehicle group had significantly severer cerebral edema, significantly increased water content of brain tissues (79.55%±0.09%) and EB content ([5.53±0.26] μg/g) as compared with sham-operated group (78.22%±0.14%, [2.55±0.13] μg/g), with significant differences (P<0.05); ICH+ CsA 10 mg group had significantly alleviated cerebral edema, significantly decreased water content of brain tissues (78.70%±0.07%) and EB content ([3.24±0.16] μg/g) as compared with ICH+vehicle group and ICH+ CsA 5 mg group (78.91%±0.11%, [4.12±0.12] μg/g), with significant differences (P<0.05). Seventy-two h after ICH, ICH+ vehicle group had decreased number of brain tissue cells around the hematoma, increased apoptosis cells (180.00±12.43) and decreased neurological deficit scale scores as compared with sham-operated group (26.00±7.29), with significant differences (P<0.05); ICH+CsA 10 mg group had decreased apoptosis cells (69.33±11.31) and increased neurological deficit scale scores as compared with ICH+vehicle group and ICH+CsA 5 mg group (95.00±8.99), with significant differences (P<0.05). Conclusion Early application of CsA can improve brain edema, blood-brain barrier permeability, decrease neuronal apoptosis and improve neurological deficit scale scores after ICH. Key words: Intracerebral hemorrhage; Cyclosporin A; Brain edema; Blood brain barrier; Neuronal apoptosis

Key concepts: Medicine, Intracerebral hemorrhage, Evans Blue, Neuroprotection, Anesthesia, Cerebral edema, Edema, Brain edema

Related papers

Back to paper searchBrowse research topicsOriginal source
Early administration of cyclosporin A providing neuroprotection in experimental rats with cerebral hemorrhage — Research Paper | ScholarLens